Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?

Elevance Health, a major health benefits provider, has shown strong performance, with its shares outperforming the broader market. The company's market cap stands at $86.9 billion, and it operates under several well-known brands. Elevance Health's stock has risen 27.6% over the past year, compared to the S&P 500's 11.8% increase.

Analysts expect the company's earnings to decline slightly in the fiscal year ending December 2026, but the earnings surprise history is positive, with Elevance Health beating consensus estimates in the last four quarters. Current analyst ratings are mostly positive, with a "Moderate Buy" consensus rating. Investment firms have varying opinions on the stock, with an average price target of $445.71, representing an 11.6% premium to the current price.